ATE464045T1 - Zusammensetzung aus milchsäure und lactoferrin - Google Patents

Zusammensetzung aus milchsäure und lactoferrin

Info

Publication number: ATE464045T1
Authority: AT; Austria
Prior art keywords: composition; lactoferrin; lactic acid; treatment; prophylaxis
Prior art date: 2004-06-23

Application number

AT05755054T

Other languages

English (en)

Inventor

Bjoern Andersch

Inger Mattsby-Baltzer

Original Assignee

Nestor Medical Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-23

Filing date

2005-06-23

Publication date

2010-04-15

2005-06-23 Application filed by Nestor Medical Ab filed Critical Nestor Medical Ab

2010-04-15 Application granted granted Critical

2010-04-15 Publication of ATE464045T1 publication Critical patent/ATE464045T1/de

Links

JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical group CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title abstract 4
102000010445 Lactoferrin Human genes 0.000 title abstract 2
108010063045 Lactoferrin Proteins 0.000 title abstract 2
CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 title abstract 2
235000014655 lactic acid Nutrition 0.000 title abstract 2
239000004310 lactic acid Substances 0.000 title abstract 2
229940078795 lactoferrin Drugs 0.000 title abstract 2
235000021242 lactoferrin Nutrition 0.000 title abstract 2
238000011282 treatment Methods 0.000 abstract 3
238000011321 prophylaxis Methods 0.000 abstract 2
108010033276 Peptide Fragments Proteins 0.000 abstract 1
102000007079 Peptide Fragments Human genes 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Oncology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Urology & Nephrology (AREA)
Gynecology & Obstetrics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)

AT05755054T 2004-06-23 2005-06-23 Zusammensetzung aus milchsäure und lactoferrin ATE464045T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0401631A SE528337C2 (sv)	2004-06-23	2004-06-23	Sammansättning innefattande mjölksyra och laktoferrin, eller ett peptidfragment därav, och användning av denna sammansättning för behandling av tillstånd i urogenitalsystemet
PCT/SE2005/000989 WO2006001766A1 (en)	2004-06-23	2005-06-23	Composition comprising lactic acid and lactoferrin

Publications (1)

Publication Number	Publication Date
ATE464045T1 true ATE464045T1 (de)	2010-04-15

Family

ID=32768753

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05755054T ATE464045T1 (de)	2004-06-23	2005-06-23	Zusammensetzung aus milchsäure und lactoferrin

Country Status (15)

Country	Link
US (1)	US20080161234A1 (de)
EP (1)	EP1784176B1 (de)
JP (1)	JP2008503576A (de)
KR (1)	KR20070048170A (de)
CN (1)	CN1972683A (de)
AT (1)	ATE464045T1 (de)
AU (1)	AU2005257722B2 (de)
BR (1)	BRPI0512503A (de)
CA (1)	CA2571183A1 (de)
DE (1)	DE602005020639D1 (de)
NZ (1)	NZ552764A (de)
RU (1)	RU2398575C2 (de)
SE (1)	SE528337C2 (de)
WO (1)	WO2006001766A1 (de)
ZA (1)	ZA200703166B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100801891B1 (ko) *	2006-11-02	2008-02-12	한상진	천연물질을 이용한 생식기 염증 예방 또는 치료용 약제학적 조성물
BRPI0809330B8 (pt) *	2007-03-30	2021-05-25	Laccure Ab	uso de um ou mais oligômeros de ácido láctico, e, composição farmacêutica
EP2130531A1 (de) *	2008-06-04	2009-12-09	Rolf Kullgren AB	Vaginalzäpfchen enthaltend Laktatsäure
BRPI1006902A2 (pt)	2009-01-23	2016-02-16	Aziende Chimiche Riunte Angelini Francesco A C R A F S P A	formulação farmacêutica ou alimentícia de liberação controlada, processo para a produção de uma forma farmacêutica ou alimentícia, sistema de liberação controlada, e, uso de um sistema de liberação controlada
KR101133723B1 (ko) *	2009-10-19	2012-04-09	최원석	소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도
US9011909B2 (en)	2010-09-03	2015-04-21	Wisconsin Pharmacal Company, Llc	Prebiotic suppositories
WO2014012805A1 (en) *	2012-07-16	2014-01-23	Laccure Ab	Pharmaceutical compositions containing oligomeric lactic acid
ITMI20122152A1 (it) *	2012-12-17	2014-06-18	Progine Farmaceutici S R L	Composizione per uso topico.
EP2992894A1 (de) *	2014-09-05	2016-03-09	Progine Farmaceutici Srl	Vaginal formulierungen für die vorbeugung und behandlung von vaginal- und zervikovaginalen infektionen
RU2637649C2 (ru) *	2014-10-30	2017-12-05	Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский Томский государственный университет" (ТГУ, НИ ТГУ)	Способ и реагент-индикатор для рН-метрии вагинальной жидкости
MX2017016991A (es) *	2017-12-20	2019-06-21	Centro De Retina Medica Y Quirurgica S C	Formulación para la administración oral de extracto de arándano azul como auxiliar en la conservación de la salud de la película lagrimal en seres humanos.
KR102683248B1 (ko)	2021-11-10	2024-07-10	장효영	질염 예방 및 치료를 위한 주입형 질 유산균 조성물
EP4260869A1 (de) *	2022-04-11	2023-10-18	Reckitt Benckiser Health Limited	Zusammensetzung mit einer kombination von lactoferrin und einem sulfatierten polysaccharid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8603338D0 (sv) *	1986-08-07	1986-08-07	Bjorn Andersch	Medel for behandling av tillstand i slidan
AU665381B2 (en) *	1992-01-23	1996-01-04	Morinaga Milk Industry Company Limited	Antibacterial agent and treatment of article therewith
AU3872797A (en) *	1996-08-12	1998-03-06	A+ Science Invest Ab	Treatment and prevention of infections, inflammations and/or tumours with lactoferrin and/or lactoferricin
CA2334370A1 (en) *	1998-06-05	1999-12-16	Nobuyuki Suzuki	Lactic acid bacterium-containing compositions, drugs and foods
US6240320B1 (en) *	1998-06-05	2001-05-29	Intermedics Inc.	Cardiac lead with zone insulated electrodes
JP3439686B2 (ja) *	1999-03-30	2003-08-25	雪印乳業株式会社	鉄強化飲料
IT1317937B1 (it) *	2000-11-17	2003-07-15	Sigma Tau Healthscience Spa	Composizione per stimolare le difese immunitarie ed il metabolismo delferro comprendente una alcanoil l-carnitina e lattoferrina.

2004
- 2004-06-23 SE SE0401631A patent/SE528337C2/sv not_active IP Right Cessation
2005
- 2005-06-23 KR KR1020077001696A patent/KR20070048170A/ko not_active Application Discontinuation
- 2005-06-23 AU AU2005257722A patent/AU2005257722B2/en not_active Ceased
- 2005-06-23 CA CA002571183A patent/CA2571183A1/en not_active Abandoned
- 2005-06-23 RU RU2007102273/15A patent/RU2398575C2/ru not_active IP Right Cessation
- 2005-06-23 ZA ZA200703166A patent/ZA200703166B/xx unknown
- 2005-06-23 US US11/628,664 patent/US20080161234A1/en not_active Abandoned
- 2005-06-23 NZ NZ552764A patent/NZ552764A/en not_active IP Right Cessation
- 2005-06-23 BR BRPI0512503-0A patent/BRPI0512503A/pt not_active IP Right Cessation
- 2005-06-23 CN CNA2005800206978A patent/CN1972683A/zh active Pending
- 2005-06-23 WO PCT/SE2005/000989 patent/WO2006001766A1/en active Application Filing
- 2005-06-23 DE DE602005020639T patent/DE602005020639D1/de active Active
- 2005-06-23 AT AT05755054T patent/ATE464045T1/de not_active IP Right Cessation
- 2005-06-23 JP JP2007518008A patent/JP2008503576A/ja not_active Abandoned
- 2005-06-23 EP EP05755054A patent/EP1784176B1/de active Active

Also Published As

Publication number	Publication date
RU2007102273A (ru)	2008-07-27
KR20070048170A (ko)	2007-05-08
DE602005020639D1 (de)	2010-05-27
EP1784176B1 (de)	2010-04-14
AU2005257722A1 (en)	2006-01-05
SE0401631D0 (sv)	2004-06-23
BRPI0512503A (pt)	2008-03-11
WO2006001766A1 (en)	2006-01-05
CA2571183A1 (en)	2006-01-05
EP1784176A1 (de)	2007-05-16
AU2005257722B2 (en)	2009-03-12
SE528337C2 (sv)	2006-10-24
ZA200703166B (en)	2008-08-27
RU2398575C2 (ru)	2010-09-10
JP2008503576A (ja)	2008-02-07
SE0401631L (sv)	2005-12-24
US20080161234A1 (en)	2008-07-03
CN1972683A (zh)	2007-05-30
NZ552764A (en)	2010-03-26

Publication	Publication Date	Title
ATE551063T1 (de)	2012-04-15	Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen
PH12017502286A1 (en)	2019-11-11	Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
EA201070121A1 (ru)	2010-06-30	Лекарственная форма, содержащая слитый белок glp-1-fc
WO2007090569A8 (de)	2008-02-28	Konditionierte blutzusammensetzung und verfahren zu deren herstellung
MX338338B (es)	2015-07-07	Composiciones y metodos utiles para el tratamiento de enfermedades respiratorias.
NZ617196A (en)	2015-06-26	Activin-actrii antagonists and uses for increasing red blood cell levels
MY153198A (en)	2015-01-29	Inhibitors of protein aggregation
WO2008054208A3 (en)	2008-10-16	Use of nutritional compositions for preventing disorders
MX341883B (es)	2016-09-07	Composicion farmaceutica para el tratamiento y prevencion de canceres.
MX2010002716A (es)	2010-07-05	Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago.
ATE464045T1 (de)	2010-04-15	Zusammensetzung aus milchsäure und lactoferrin
WO2006013441A3 (en)	2006-04-06	Use of probiotic bacteria for the preparation of topical compositions for skin protection
MY138708A (en)	2009-07-31	Biaryloxymethylarenecarboxylic acids
WO2008079270A3 (en)	2008-10-16	Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
MX2007006284A (es)	2007-06-15	Acidos biariloximetilarenocarboxilicos.
WO2007134118A3 (en)	2009-09-11	Protein based composition and methods of using same
IL194353A0 (en)	2011-08-01	Lysobactin amides
UA107177C2 (uk)	2014-12-10	Імуногенна композиція цвс2 та спосіб приготування такої композиції
DE502005007472D1 (de)	2009-07-23	Desoxo-nonadepsipeptide
ATE455789T1 (de)	2010-02-15	Substituierte nonadepsipeptide
DE502005005652D1 (de)	2008-11-20	Heterocyclyl-substituierte nonadepsipeptide
WO2007084964A3 (en)	2007-12-27	Pharmaceutical composition comprising a protein pump inhibitor and protein component
NO20100744L (no)	2010-08-13	Redusert kjonnsmodning i fisk
IL182297A (en)	2010-12-30	Use of winter savory (satureja montana) or the extracts thereof for the preparation of medicaments for the treatment of the premature ejaculation
WO2007047235A3 (en)	2007-07-12	Compositions and methods for treatment of airway hypersecretion

Legal Events

Date	Code	Title	Description
2010-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties